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Effects of High-Fat Feeding on Ectopic Fat Storage and
Postprandial Lipid Metabolism in Mouse Offspring
Petronella A. van Ewijk1,2,3, Sabina Paglialunga1,3, M. Eline Kooi2,3,4, Patricia M. Nunes5, Anne Gemmink3,6, Jos Slenter2,
Esther Kornips1,3, Johanna A. J€orgensen1,3, Joris Hoeks1,3, Joachim E. Wildberger2,4, Matthijs K.C. Hesselink3,6,
Jan F.C. Glatz4,7, Arend Heerschap5, Sander Kersten8,9, Patrick Schrauwen1,3, and Vera B. Schrauwen-Hinderling2,3
Objective: Parental high-fat feeding was proposed to negatively impact metabolic health in offspring.
Here, the ectopic fat storage in heart and liver in offspring was investigated, and the effects on mitochon-
drial function, de novo lipogenesis, and postprandial lipid metabolism were explored in detail.
Methods: Male and female mice received either a high-fat (HF) or standard chow (LF) diet during mating,
gestation and lactation. All offspring animals received the HF diet.
Results: Abdominal visceral adipose tissue tended to be higher in HF/HF mice. Cardiac lipid content
was also higher in the HF/HF mice (LF/HF vs. HF/HF: 1.03% 6 0.08% vs. 1.33% 6 0.07% of water signal,
P 5 0.01). In contrast, hepatic lipid content tended to be lower in HF/HF mice compared to LF/HF mice.
A severely disturbed postprandial lipid clearance was revealed in HF/HF mice by the results from the tri-
glyceride (TG) tolerance tests (LF/HF vs. HF/HF: 6,753 6 2,213 vs. 14,367 6 1,978 mmol l21 min21,
P 5 0.01) and 13C-fatty acid retention test (LF/HF vs. HF/HF: 2.73% 6 0.85% vs. 0.89% 6 0.26% retention
from bolus, P 5 0.04), which may underlie the lower hepatic lipid content.
Conclusions: Here it is shown that HF diet negatively impacts postprandial TG clearance in offspring
and results in an overall metabolic unfavorable phenotype and ectopic lipid deposition in the heart and in
visceral storage sites.
Obesity (2015) 23, 2242–2250. doi:10.1002/oby.21235
Introduction
In spite of large-scaled efforts to promote a healthy body weight, the
prevalence of obesity and metabolic syndrome is still rising (1),
thereby increasing the risk for diabetes (2) and cardiovascular disease.
It is unresolved to what extent this dramatic increase is accounted for
by changed dietary habits. An underestimated factor that may exacer-
bate the effects of an unhealthy lifestyle may be the presence of obesity
in the previous generation. There is evidence for a carry-over effect
from one generation to the next. For instance, positive relationships
between maternal pregravid BMI and birthweight (3), fetal insulin
resistance (4), and fetal body fat percentage have been reported (5).
Moreover, children of mothers with obesity have increased risk to
develop metabolic syndrome (6) and congenital heart defects (7).
More specifically, in non-human primates it was found that maternal
exposure to a high-fat diet (31.6 energy%) resulted in a metabolic syn-
drome phenotype in 60% of the offspring and increased the risk for
non-alcoholic fatty liver disease (NAFLD) (8). It also was shown in a
rodent model that increasing the dietary fat content during pregnancy
and lactation suffices to adversely affect the offspring in terms of pro-
moting hepatic lipid storage and inflammation and diminishing
markers of mitochondrial function and de novo lipogenesis (9). When
examining lipid metabolism, most studies are limited to the investiga-
tion of fasted concentrations of plasma metabolites. However, post-
prandial lipid metabolism is also an important player in mediating
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metabolic risk, which is not necessarily reflected in fasted plasma con-
centrations. We therefore investigated how the postprandial response
to a lipid load is modified in offspring of high-fat-fed mice. We inves-
tigated the effect on muscle, cardiac, and hepatic steatosis and function
using non-invasive techniques. We report that offspring of mice that
were exposed to an obesogenic high-fat diet have increased visceral
adipose tissue (VAT) mass and increased cardiac lipid content, while
hepatic lipid content tended to be lower due to delayed postprandial
clearance of dietary triglyceride (TG).
Methods
Animal model and study set up
The Institutional Ethics Committee on Animal Welfare approved all
experiments. C57Bl/6 mice (breeding couples from Charles River)
were housed under standard conditions at 258C with a 12:12-h light-
dark cycle with ad libitum access to water and diet. Mice were ran-
domly assigned to either a high-fat (HF) diet (45% kcal fat of which
31% saturated, 36% mono-unsaturated, 33% poly-unsaturated fatty
acids, 20% kcal protein, 35% kcal carbohydrate, Research Diets, New
Brunswick, NJ) or standard chow (LF) diet (9% kcal fat, 33% kcal
protein, 58% kcal carbohydrate, ssniff Spezialdi€aten GmbH). Mice
were fed their assigned diet at least 6 weeks before mating and the
diet was continued during gestation and lactation. Weight gain and
food intake were measured weekly (Supporting Information Figure
S1). Littersize was similar in both groups. At weaning, all offspring
was fed the HF diet, generating two experimental groups: HF/HF and
LF/HF. Body weight and food intake was determined each week and
was similar in both groups (Supporting Information Figure S2). Meas-
urements were only performed in male offspring, because of the possi-
bility of sexual dimorphism. Male offspring (n513 from each group)
underwent a glucose tolerance test (GTT) at 12 weeks of age, and car-
diac function and cardiac -, hepatic - and abdominal visceral fat was
measured at 15 weeks of age. In a parallel group of mice, cardiac and
hepatic mitochondrial function was determined at 12 weeks of age.
A third, parallel group of male offspring (n 5 9 HF/HF and n 5 9 LF/
HF) underwent a triglyceride tolerance test (TTG) at 10 weeks of age
and cardiac and hepatic lipid retention and de novo lipogenesis
(DNL) was measured at 12 weeks of age. The study design is also
presented in the Supporting Information Figure S3. Changes in
ectopic fat deposition during early adulthood (around 15 weeks) have
been reported before in mice when the previous generation was
exposed to HF feeding (9). To study underlying mechanisms, we per-
formed detailed measurements in mice around 10-15 weeks of age.
Magnetic resonance imaging and spectroscopy
in vivo
Cardiac function, cardiac-, hepatic-, and abdominal visceral fat con-
tent were measured using magnetic resonance imaging (MRI) and
spectroscopy (MRS). Mice were anesthetized with 2% isoflurane and
0.4 l min21 of O2 and placed in a cradle with warm waterbed, in a
quadrature volume coil (ø 35 mm, transmit-receive, Bruker Biospin)
of 7 Tesla MR System (Bruker Biospin GmbH, Ettlingen, Germany).
Visceral fat content
Coronal T1-weighted spin-echo images (matrix size: 256 3 256,
FOV: 50 3 50 mm2, TE: 9.1 ms, TR: 500 ms, NA: 1, slice thick-
ness: 1 mm) were obtained. Using in-house developed software,
VAT content was determined in the three-dimensional region from
the middle of the left kidney to the middle of the bladder. Images
were checked individually and manually edited in MRIcron (10).
Cardiac and hepatic lipid content assessed
by 1H-MRS
Cardiac 1H-MRS was performed using cardiac-triggered and
respiratory-gated point resolved spectroscopy (PRESS, TE 5 9.1 ms,
TR 5 2,000 ms). Spectra were acquired from a 4-ll voxel in the inter-
ventricular septum. A water-suppressed spectrum was acquired
(NSA 5 512) as well as a reference spectrum (with non-suppressed
water signal, NSA 5 64). Spectra were fitted using the AMARES
algorithm in jMRUI (11). The sum of the TG peaks at 1.55, 1.26, and
0.85 ppm was expressed as percentage of the unsuppressed water
signal.
Hepatic lipid content was determined as described for cardiac lipid,
but with a water-suppressed spectrum (NSA 5 128) and water spec-
trum (NSA 5 64) from a 18-ll voxel.
Cardiac function assessed by MRI
Bright blood cine images in four-chamber view (4CH), long axis
view (LA), and two slices of short axis view (SA) were acquired [1-
2 mm under the mitral valve and at the base of the papillary muscle
were acquired as described before (12)]. End-diastolic volume
(EDV), end-systolic volume (ESV), and ejection fraction (EF) were
calculated using the modified Simpson Rule (12).
Glucose tolerance test, plasma insulin, and
plasma metabolites
Mice were fasted for 6 h and injected intraperitoneally with glucose
(2 mg g21 body weight in 200 ll of sterile solution) as reported ear-
lier (13).
Fasting plasma insulin levels were determined using a Meso Scale
Discovery (MSD) assay (Gaithersburg, USA) and HOMA index was
calculated. At 12 weeks of age, venous blood was collected in
EDTA-containing tubes (1 mg ml21) after a 5-h fast and plasma TG
and NEFA levels were determined (Roche, Schlieren, Switzerland
and Wako Chemicals, Neuss, Germany, respectively).
Biochemical TG determination in gastrocnemicus
TG levels in gastrocnemius muscle were measured using the method
of Schwartz and Wolins (14).
Mitochondrial isolation and respiration
measurements
Mice were anaesthetized and killed by decapitation. Mitochondria were
isolated as previously described with minor modifications (15). Briefly,
heart and liver were excised and placed in ice-cold isolation buffer,
rinsed, and minced on ice. Heart tissue was further digested with an enzy-
matic treatment (protease, Sigma). After homogenation and centrifuga-
tion, the resulting pellet was re-suspended in isolation buffer (HIB for
heart and LIB without BSA for liver preparations) and centrifuged in two
steps (at 800g and 8,500g at 48C).The final mitochondrial pellet was re-
suspended in HIB and homogenized. Mitochondrial protein content was
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determined by Fluram assay (15). Mitochondrial respiration (heart: 0.1
mg ml21 and liver: 0.25 mg ml21) was determined at 378C in a two-
chamber Oxygraph (OROBOROSVR Instruments, Innsbruck, Austria)
using pyruvate (5 mM) plus malate (3 mM) for heart or glutamate
(5 mM) plus malate (3 mM) for liver and palmitoyl-coenzyme A (CoA)
(50 lM) plus carnitine (2 mM) as substrates. ADP (450 lM) and oligo-
mycin (1 lg ml21) were added to obtain state 3 and state 4 respirations,
respectively.
Mitochondrial DNA and copy number
Mitochondrial DNA copy number was determined by the ratio of
COX2 expression over UCP2 expression as described previously (16).
Hepatic de novo lipogensis
Fractional contribution of DNL to the hepatic lipid pool was deter-
mined using 1H/2H NMR spectroscopy of liver extracts after 2H2O
enrichment (Sigma-Aldrich, St Louis, MO) as described before (17).
Total hepatic TG and DNL fraction were quantified against pyraz-
ine. The ratio between 2H enriched body-water and the 2H enrich-
ment of hepatic TG methyl hydrogens determines the contribution
of DNL to the total hepatic TG pool (18).
Cardiac and hepatic lipid retention
To determine the contribution of dietary fat to myocardial and
hepatic TG, mice were fasted for 4 h and given an oral load of
[U-13C] algal-lipid mixture (Cambridge Isotope Laboratories, Ando-
ver, MA, 5 g kg21 body weight). Four hours later, animals were
killed and hearts and livers were freeze-clamped and lipids were
extracted and analyzed by proton-decoupled 13C-NMR spectra of
cardiac and hepatic lipids as described before (17).
Dietary lipid absorption to heart or liver (% of bolus) is given as 5
total cardiac or hepatic TG ðlmolg-1Þ313C-enrichmentð%Þ3heart or liver weightðgÞ
oral lipid supplyðlmolÞ
Triglyceride tolerance test
Mice were shortly fasted (4 h) and received an oral bolus of olive
oil (11 g kg21). Plasma TG was assessed every hour for the next
4 h with a standard TG meter (Cardiocheck, Belgium).
mRNA expression of LPL and modulators of LPL
in hepatic and white adipose tissue
For analyses of mRNA of LPL, ANGPTL4, GPIHBP1, and PPARc in
mouse white adipose tissue (WAT) and mRNA of hepatic lipase,
ANGPTL4, ANGPTL3, apoE, and apoC3 in liver tissue, total RNA was
isolated with TRIzol reagent (Invitrogen, Breda, The Netherlands)
according to manufacturer’s instructions. One lg of total RNA was
reverse transcribed using iScript (Bio-Rad, Veenendaal, The Nether-
lands). cDNA was PCR-amplified with Platinum Taq DNA polymerase
(Invitrogen) on a Bio-Rad CFX384 Real Time System using Sensimix
(Bioline, GC Biotech, Alphen aan de Rijn, The Netherlands). Ribosomal
protein 36B4 mRNA served as control. PCR primer sequences (Primer-
Bank) were ordered from Eurogentec (Seraing, Belgium).
Statistical analysis
Results are expressed as means 6 standard error of the mean (SEM).
Statistical analysis was performed using IBM SPSS Statistics for
Windows, Version 20.0 (Armonk, NY: IBM Corp). To evaluate
effects between the two experimental groups, a two-tailed Student’s
t-test was used. Significance was set at P 0.05.
Results
Body weight, organ weight, and visceral fat
content
Body weight tended to be increased at 12 weeks of age (LF/HF vs.
HF/HF: 25.5 6 0.7 vs. 27.3 6 0.7 g, P 5 0.08) in HF/HF mice from
group 1. VAT volume, also tended to be higher (LF/HF vs. HF/HF:
581.9 6 33.8 vs. 881.2 6 106.7 ll, P 5 0.08, Figure 1). No differ-
ence in heart or liver weight was observed.
Fasted plasma metabolites and glucose
tolerance test
Fasted plasma glucose, insulin, plasma TG and NEFA levels were
similar in both dietary groups (Table 1). Therefore, HOMA-IR was
also similar. Early exposure to a HF diet did not change glucose tol-
erance (Figure 2).
Skeletal muscle lipid content
Skeletal muscle lipid content was not affected by early exposure to
a HF diet (LF/HF vs. HF/HF: 0.015 6 0.002 vs. 0.012 6 0.002
TG ll21 protein, P 5 ns).
Cardiac function, lipid content, and mitochondrial
respiration
Early exposure to a HF diet resulted in significantly increased cardiac
lipid content at 15 weeks of age (LF/HF vs. HF/HF: 1.03% 6 0.08%
vs. 1.33% 6 0.07% of water signal, P 5 0.01, Figure 3). To investigate
if changes in cardiac lipid content were associated with alterations in
mitochondrial oxidative capacity, mitochondrial respiration was meas-
ured in isolated mitochondria in parallel groups. Prenatal exposure to
the HF diet did not result in alterations in pyruvate or palmitoylCoA1
carnitine-supported respiration or mitochondrial copy number at 12
weeks of age. These differences in cardiac lipid content furthermore
did not translate into differences in cardiac systolic function (EDV,
ESV and EF, Supporting Information Figure S4).
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Hepatic lipid content and mitochondrial function
To investigate if similar effects are found in liver, hepatic lipid con-
tent was determined using 1H-MRS. Typical spectra are shown in
Figure 4. In contrast to the elevated lipid content in the heart,
hepatic fat content tended to be reduced in mice exposed early to
HF at 15 weeks of age (LF/HF vs. HF/HF: 4.50% 6 0.43% vs.
3.64% 6 0.18% of water signal, P 5 0.07). These results were con-
firmed by ex vivo analysis of hepatic fat content in a parallel group
of mice killed at 12 weeks of age (LF/HF vs. HF/HF:
271.67 6 49.21 vs. 169.07 6 16.18 lmol g21 of liver, P 5 0.06).
Despite the reduced hepatic fat content in young mice, mitochon-
drial respiration on glutamate was significantly reduced in mice
exposed early to the HF diet at 12 weeks of age (State 3: 1125 6 96
vs. 902 6 41 pmol(s 3 mg)21, P 5 0.05). No differences in mito-
chondrial respiration with palmitoylCoA as a substrate were
observed between groups, and mitochondrial DNA copy number
was not affected by early exposure to the HF diet (Table 2).
Postprandial lipid handling and de novo
lipogenesis
As both cardiac and hepatic lipid content may be affected by dietary
fat handling, we first investigated cardiac and hepatic dietary lipid
retention. Cardiac lipid retention was similar in both groups (LF/HF
vs. HF/HF: 0.21% 6 0.06% vs. 0.20% 6 0.07% of bolus, NS, Figure
5A). However, early exposure to a HF diet resulted in a marked 3.1
fold reduction of hepatic lipid retention after a meal (LF/HF vs. HF/
HF: 2.73% 6 0.85% vs. 0.89% 6 0.26% retention from bolus,
Figure 1 (A) Abdominal VAT was determined in the three-dimensional region from half the size of the left kidney to half the size of the bladder (from
left to right, from top to bottom). (B) Mean (6 SEM) abdominal visceral fat content (ll) per group. A tendency for differences in VAT content between
the groups is indicated with § P 0.1. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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P 5 0.04, Figure 5B). These results are consistent with a reduction
in plasma TG clearance upon a lipid load in HF/HF mice. Both
groups were subjected to an oral bolus of olive oil and determined
postprandial TG plasma concentrations, which were much higher in
the HF/HF group compared to LF/HF group (6,753 6 2,213 vs.
14,367 6 1,978 mmol l21 min21, P 5 0.01, Figure 6). The contribu-
tion of DNL to the hepatic lipid content, traced by 2H2O, was also
determined and tended to be higher in the HF/HF group (LF/HF vs.
HF/HF: 4.24% 6 0.82% vs. 7.59% 6 1.38%, P 5 0.06, Figure 5C).
Expression of LPL and modulators of LPL
activity
The reduced dietary lipid retention in the liver can be due to a
reduced capacity of the liver to take up dietary lipids or to a reduced
clearance in LPL-rich tissue such as adipose tissue. Therefore, we
investigated expression of genes involved in these processes in liver
and adipose tissue. No difference in hepatic Angtpl4, Angptl3,
ApoE, and ApoC3 mRNA expression levels was found between LF/
HF and HF/HF mice. Hepatic lipase showed a trend towards lower
expression in mice exposed early to the HF diet compared to control
mice (HF/HF vs. LF/HF: 0.89 6 0.08 vs. 1.08 6 0.06, P 5 0.08). The
expression of LPL, Angtpl4, Gpihbp1 and PPARc in WAT was sim-
ilar in both groups (Supporting Information Table S1).
Discussion
It is generally accepted that the consumption of fat-rich diets favors
the development of obesity and cardiovascular disease, often accom-
panied by accumulation of ectopic lipids and impaired postprandial
lipid handling. An underestimated factor in the development of this
phenotype may be the long-lasting influence of the exposure to an
obesogenic environment during very early development (in utero
and during lactation). In the present study we investigated whether
exposure to an obesogenic HF diet increases the susceptibility for
lipotoxic effects in the next generation. We focused on the effect on
glucose tolerance, visceral, hepatic, and cardiac fat, and cardiac
function. Mitochondrial function was also determined and effects on
postprandial lipid handling were investigated.
We describe for the first time that exposure to a HF diet resulted in
major disturbances in dietary lipid handling in offspring with
increased postprandial plasma TG concentrations. Because it is well
established that postprandial hypertriglyceridemia is a risk factor for
cardiovascular disease (21), exposure to a HF diet during early
development may be an important risk factor for morbidity and
mortality later in life. It is important to note that fasted TG plasma
concentrations were similar in both groups, showing the added
value of postprandial plasma sampling in investigating metabolic
disturbances.
HF feeding resulted in an altered pattern of ectopic fat storage with
a tendency for reduced hepatic lipid content and significantly
increased cardiac lipid content in offspring at week 15 of age. In
general, elevated hepatic lipid content is recognized to be a
Figure 2 (A) Mean (6 SEM) plasma glucose concentrations during the glucose tolerance test. Only 15 min after
the start of the IPGTT, a significant difference in plasma glucose concentration was found, indicated with
* P 0.05. (B) Area under the curve (AUC) of the glucose concentration during the ipGTT. Glucose clearance
was similar for the LF/HF and HF/HF mice.
TABLE 1 Basic characteristics
LF/HF HF/HF
Body weight (g) 25.48 6 0.66 27.28 6 0.70§
Heart weight (g) 0.19 6 0.01 0.18 6 0.01
Liver weight (g) 0.96 6 0.02 0.94 6 0.06
WAT weight (g) 0.77 6 0.08 1.00 6 0.11
Plasma TG (mmol l21) 0.86 6 0.07 0.82 6 0.05
Plasma NEFA (mmol l21) 0.40 6 0.03 0.49 6 0.07
Plasma glucose (mmol l21) 14.0 6 0.8 13.4 6 0.6
Insulin (pmol l21) 120 6 8 135 6 14
HOMA-IR 10.4 6 0.9 10.9 6 1.1
Results are expressed as means 6 SEM for 11 LF/HF mice and 11 HF/HF mice
from group 1. WAT, white adipose tissue; TG, triglycerides; NEFA, nonesterified
fatty acids; HOMA-IR, Homeostasis Model Assessment-estimated Insulin Resist-
ance, with § indicating a trend (§ 5 P0.1) between the groups .
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determinant in the development of insulin resistance and diabetes,
and a reduced liver fat content would be considered a beneficial
adaption. However, the reduction in hepatic fat was associated with
a disturbed TG clearance and severely decreased hepatic lipid reten-
tion from a meal in the HF/HF group, which is probably the under-
lying reason for the low liver fat content in the current study. Con-
sequently, a low liver fat content is most likely a reflection of
disturbances in postprandial TG clearance rather than a reflection of
good metabolic health.
When the liver is taking up lipids in the postprandial state, next to
the action of hepatic lipase, TG uptake in the liver largely depends
on the clearance of chylomicron particles by LPL in adipose tissue
or skeletal muscle. To investigate the origin of the impaired TG
clearance, we explored mRNA expression of PPAR-c and LPL as
well as known LPL modulators such as Angptl4, Gpihbp1 in WAT
and expression of liver-specific LPL modulators (angiopoietin-like
proteins Angtpl3, Angtpl4 and apolipoproteins ApoE, ApoC3) as
well as hepatic lipase. We found a tendency for reduced mRNA
expression of hepatic lipase in HF/HF mice, which may partially
underlie the decreased uptake of dietary lipid during a meal and
may contribute to the elevated plasma TG concentrations after an
oral lipid load in HF/HF mice.
Next to these disturbances in postprandial TG clearance, the HF/HF
group shows a tendency for elevated hepatic DNL. DNL is known
to be elevated in animal models of NAFLD and in humans with
NAFLD and may contribute to the development of a fatty liver in
the long term. In a study investigating the origin of hepatic fat in
non-alcoholic steatohepatitis (NASH) patients’ DNL accounted for
20-30% of fatty acids in the liver (22). Future, more prolonged stud-
ies will have to investigate whether in the long term this pathway
will actually outweigh the diminished dietary lipid uptake in the
liver and whether this will lead to an increased hepatic fat content
in the offspring of the HF-fed mice.
In addition to the postprandial hypertriglyceridemia, which represent
a cardiovascular risk factor, non-invasive MR imaging revealed that
early exposure to a HF diet resulted in a tendency for elevated
VAT. It is known that visceral adiposity is associated with and even
predicts the development of coronary heart disease, (23) hyperten-
sion (23) and type 2 diabetes (24), further suggesting that early
exposure to a HF diet results in a less preferable metabolic pheno-
type. The fact that the fat content of the maternal diet is a strong
determinant for later metabolic health is of particular relevance as
the typical Western diet contains high amounts of fat and is widely
consumed, also by women of child-bearing age. Future research
Figure 3 Representative myocardial 1H-MR spectrum obtained from (A) a LF/HF mouse and (B) a HF/HF mouse. Metabolite peaks were
assigned as described previously (19,20). 0. residual (suppressed) water signal, 4.7 ppm; 1. taurine, 3.38 ppm; 2. carnitine, 3.21 ppm; 3. crea-
tine-CH3, 2.99 ppm; 4. TG CH5CH-CH2-CH5CH, 2.72 ppm; 5. TG CaH2COO, 2.20 ppm; 6. TG CH2-CH5CH-CH2, 2.0 ppm; 7. TG
CbH2CH2COO, 1.55 ppm; 8. TG –(CH2)n-, 1.26 ppm; and 9. TG-CH3, 0.85 ppm. (C) Mean 6 SEM myocardial lipid content of mice. Significant
differences between the dietary groups are indicated with * P 0.05.
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should further investigate the mechanism underlying the identified
derangements in postprandial lipid partitioning in order to be able to
prevent the development of postprandial hypertriglyceridemia
induced by early exposure to a HF diet.
Contrary to the liver, cardiac lipid content was significantly
increased. It is well known that cardiac tissue is able to take up cir-
culating TG via the action of cardiac LPL. Therefore, unlike the
liver, the heart is not dependent on the clearance of chylomicrons
Figure 4 Representative hepatic 1H-MR spectrum obtained from (A) a LF/HF mouse and (B) a HF/HF mouse. Metabolite peaks were
assigned as described previously (19,20). 0. residual (suppressed) water signal, 4.7 ppm; 1. taurine, 3.38 ppm; 2. carnitine, 3.21 ppm; 3. TG
CH5CH-CH2-CH5CH, 2.72 ppm; 4. TG CaH2COO, 2.20 ppm; 5. TG CH2-CH5CH-CH2, 2.0 ppm; 6. TG CbH2CH2COO, 1.55 ppm; 7. TG
–(CH2)n-, 1.26 ppm; and 8. TG-CH3, 0.85 ppm. (C) Mean 6 SEM hepatic lipid content of mice. A tendency for differences between the die-
tary groups is indicated with § P 0.1.
TABLE 2 Hepatic and cardiac mitochondrial respiration levels [pmol (s 3 mg21)21]
Liver LF/HF HF/HF Heart LF/HF HF/HF
Glutamate-supported respiration Pyruvate-supported respiration
State 3 1124.51 6 95.52 901.76 6 40.69* State 3 3502.23 6 355.07 3649.58 6 222.57
State 4 254.88 6 21.53 217.27 6 14.06 State 4 667.40 6 41.90 691.71 6 34.57
RCR 4.46 6 0.22 4.24 6 0.23 RCR 5.17 6 0.34 5.30 6 0.26
PalmitoylCoA1carnitine-supported respiration PalmitoylCoA1carnitine-supported respiration
State 3 585.26 6 82.73 570.94 6 82.41 State 3 2915.03 6 249.06 3218.72 6 221.94
State 4 262.90 6 42.12 223.17 6 15.87 State 4 654.05 6 77.60 565.94 6 34.40
RCR 2.28 6 0.22 2.46 6 0.20 RCR 5.03 6 0.60 5.83 6 0.46
Results are expressed as means 6 SEM for 11 LF/HF mice and 11 HF/HF mice. ADP-stimulated (state 3) respiration was induced by the addition of ADP; state 4 respira-
tion was attained upon addition of the ATPsynthase inhibitor oligomycin. Additionally, RCR (respiratory control ratio, S3/S4) respiration is presented, with * indicating statis-
tical significance (* 5 P 0.05) between the groups.
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Figure 5 Mean 6 SEM of (A) cardiac and (B) hepatic [U-13C] lipid absorption and contribution of de novo
lipogenesis to hepatic TG content. No difference in cardiac lipid absorption after a meal was found, but HF/
HF mice showed significantly reduced hepatic lipid absorption after a meal (P 5 0.04) compared to the LF/
HF at 12 weeks of age. (C) A trend (P 5 0.06) for elevated contribution of DNL to hepatic TG content was
found in the HF/HF group compared to the LF/HF group. Significant differences between the dietary groups
are indicated with §P 0.1 and *P 0.05.
Figure 6 (A) One hour after administration of the bolus, a significant difference in plasma TG concentrations was found between the
HF/HF and LF/HF group during the TG tolerance test, performed at 12 weeks of age. (B) Incremental area under the curve (iAUC) is
significantly higher (P 5 0.01) in the HF/HF mice compared to the LF/HF mice. Significant differences between the dietary groups are
indicated with §P 0.1 and *P 0.05; means 6 SEM are shown.
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by other LPL-rich tissues (like skeletal muscle and adipose tissue)
for TG uptake. The increased cardiac lipid content thus most likely
is due to the elevated plasma TG levels observed postprandially.
Moreover, it has been suggested that cardiac lipid accumulation may
hamper cardiac function by so-called lipotoxic mechanisms (25).
However, lipid accumulation in tissue does not necessarily lead to
lipotoxicity and tissue dysfunction when the excess lipids are prop-
erly stored into lipid droplets. In this study, no compromised mito-
chondrial function and cardiac function were observed, despite the
changes in cardiac lipid content. It is important to note that the
increment in cardiac lipid content in the current study is modest
when compared to genetic animal models where cardiac lipid con-
tent is often severely manipulated, which is then associated with car-
diac dysfunction (26-28). The outcome of the present study is in
line with earlier findings in rat (29) and men (30,31), showing that a
moderate, but physiological change in cardiac fat content is not a
strong determinant of cardiac function.
With the current design, we could not distinguish between the
effects of maternal obesity independently from the maternal diet.
Maternal obesity alone may also be a risk factor for impaired meta-
bolic health [e.g., Ref 32]. Another study limitation is that the meas-
urements were limited to male offspring during young adulthood
and future studies will have to determine the effects in female mice
and investigate the longer term effects.
In summary, early exposure to a HF diet caused yet unrecognized
adaptations resulting in delayed postprandial TG clearance, imposing
an increased cardiovascular risk on offspring of HF-fed mice.
Impaired TG clearance may in turn be underlying the modest
hepatic lipid retention from a meal in the HF/HF mice, resulting in
the initially low hepatic fat content, and at the same time, the high
postprandial TG levels may favor cardiac lipid accumulation. Future
studies are needed to investigate the longer term effects. The stimu-
lation of DNL and visceral fat storage let us anticipate that on the
longer term, hepatic fat content will be increased in the group of
early HF exposure. Other studies on prenatal HF exposure have
often reported elevated hepatic fat content. Future studies are needed
to confirm these mechanisms in the human setting, opening new
avenues to combat postprandial hypertriglyceridemia caused by early
HF exposure.O
VC 2015 The Obesity Society
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